Malaria: a haematological disease.
Plasmodium falciparum malaria remains a major cause of mortality throughout the tropical world. Haematological abnormalities are considered a hallmark of malaria, bearing an impact on final outcome and representing indices of prognostic and follow-up value. These include severe anaemia, coagulation disturbances, leukocyte numerical or functional changes and spleen involvement. Anaemia involves red blood cell lysis due to parasite invasion, as well as mechanisms of intravascular haemolysis and decreased erythropoiesis. Exchange or blood transfusion is mainly recommended in the management of these patients. Haemorrhagic complications in severe malaria are relatively rare despite prominent thrombocytopenia and dysfunction in the coagulation pathway. Numerical, as well as functional changes in the white blood cell are less dramatic than other blood cell series, but still, remain a significant index of disease progression and ultimate prognosis. Finally, the role of the spleen in severe malaria is multifactorial. Care and vigilance should be taken against splenic rupture which is fatal and can occur despite appropriate antimalarial prophylaxis and treatment.
Department of Internal Medicine, University Hospital of Patras, Rio, Greece. k.akinosoglou07@imperial.ac.uk
Karolina S
KS
Akinosoglou
Elena E
EE
Solomou
Charalambos A
CA
Gogos
D000740:Anemia / Q000097:blood / Q000209:etiology / Q000628:therapy; D000962:Antimalarials / Q000008:administration & dosage / Q000627:therapeutic use; D001777:Blood Coagulation; D001803:Blood Transfusion; D004920:Erythropoiesis; D006461:Hemolysis; D006801:Humans; D007962:Leukocytes / Q000473:pathology; D016778:Malaria, Falciparum / Q000097:blood / Q000150:complications / Q000628:therapy; D010963:Plasmodium falciparum / Q000187:drug effects / Q000502:physiology*; D013163:Splenomegaly / Q000097:blood / Q000209:etiology / Q000628:therapy; D013921:Thrombocytopenia / Q000097:blood / Q000209:etiology / Q000628:therapy
D000962:Antimalarials